Compare RAIL & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAIL | ACB |
|---|---|---|
| Founded | 1901 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Railroads | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.9M | 232.3M |
| IPO Year | 2005 | 2016 |
| Metric | RAIL | ACB |
|---|---|---|
| Price | $7.22 | $3.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 181.6K | ★ 1.7M |
| Earning Date | 05-04-2026 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.94 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $500,991,000.00 | N/A |
| Revenue This Year | $6.54 | $6.31 |
| Revenue Next Year | $30.90 | N/A |
| P/E Ratio | $22.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.11 | $2.56 |
| 52 Week High | $14.90 | $6.67 |
| Indicator | RAIL | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 69.72 |
| Support Level | N/A | $3.22 |
| Resistance Level | $10.03 | $3.91 |
| Average True Range (ATR) | 0.42 | 0.18 |
| MACD | -0.06 | 0.08 |
| Stochastic Oscillator | 4.45 | 87.70 |
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.